Global Newcastle Disease Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030
Summary
Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans.
Newcastle disease can be controlled by the use of vaccines. There are many Newcastle disease vaccines suitable for use in commercial chickens.
According to APO Research, The global Newcastle Disease Vaccine market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Newcastle Disease Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Newcastle Disease Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Newcastle Disease Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Newcastle Disease Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Newcastle Disease Vaccine include Merial, CEVA, QYH Biotech, Ringpu Biology, Yebio, Harbin Veterinary Research Institute, Merck Animal Health, DHN and Zoetis, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Newcastle Disease Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Newcastle Disease Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Newcastle Disease Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Newcastle Disease Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Newcastle Disease Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Newcastle Disease Vaccine sales, projected growth trends, production technology, application and end-user industry.
Newcastle Disease Vaccine segment by Company
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Newcastle Disease Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Newcastle Disease Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Newcastle Disease Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Newcastle Disease Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2019-2030).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Newcastle Disease Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Newcastle Disease Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Newcastle Disease Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans.
Newcastle disease can be controlled by the use of vaccines. There are many Newcastle disease vaccines suitable for use in commercial chickens.
According to APO Research, The global Newcastle Disease Vaccine market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Newcastle Disease Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Newcastle Disease Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Newcastle Disease Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Newcastle Disease Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Newcastle Disease Vaccine include Merial, CEVA, QYH Biotech, Ringpu Biology, Yebio, Harbin Veterinary Research Institute, Merck Animal Health, DHN and Zoetis, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Newcastle Disease Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Newcastle Disease Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Newcastle Disease Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Newcastle Disease Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Newcastle Disease Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Newcastle Disease Vaccine sales, projected growth trends, production technology, application and end-user industry.
Newcastle Disease Vaccine segment by Company
- Merial
- CEVA
- QYH Biotech
- Ringpu Biology
- Yebio
- Harbin Veterinary Research Institute
- Merck Animal Health
- DHN
- Zoetis
- ChengDu Tecbond
- Elanco (Lohmann)
- FATRO
- CAVAC
- Vaksindo
- Live Vaccines
- Killed Vaccines
- Chicken
- Duck & Goose
- Other
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Newcastle Disease Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Newcastle Disease Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Newcastle Disease Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Newcastle Disease Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2019-2030).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Newcastle Disease Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Newcastle Disease Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Newcastle Disease Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Newcastle Disease Vaccine Market Size, 2019 VS 2023 VS 2030
1.3 Global Newcastle Disease Vaccine Market Size Estimates and Forecasts (2019-2030)
1.4 Global Newcastle Disease Vaccine Sales Estimates and Forecasts (2019-2030)
1.5 Global Newcastle Disease Vaccine Market Average Price (2019-2030)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 GLOBAL NEWCASTLE DISEASE VACCINE MARKET DYNAMICS
2.1 Newcastle Disease Vaccine Industry Trends
2.2 Newcastle Disease Vaccine Industry Drivers
2.3 Newcastle Disease Vaccine Industry Opportunities and Challenges
2.4 Newcastle Disease Vaccine Industry Restraints
3 NEWCASTLE DISEASE VACCINE MARKET BY MANUFACTURERS
3.1 Global Newcastle Disease Vaccine Revenue by Manufacturers (2019-2024)
3.2 Global Newcastle Disease Vaccine Sales by Manufacturers (2019-2024)
3.3 Global Newcastle Disease Vaccine Average Sales Price by Manufacturers (2019-2024)
3.4 Global Newcastle Disease Vaccine Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
3.5 Global Newcastle Disease Vaccine Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Newcastle Disease Vaccine Manufacturers, Product Type & Application
3.7 Global Newcastle Disease Vaccine Manufacturers Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Newcastle Disease Vaccine Market CR5 and HHI
3.8.2 Global Top 5 and 10 Newcastle Disease Vaccine Players Market Share by Revenue in 2023
3.8.3 2023 Newcastle Disease Vaccine Tier 1, Tier 2, and Tier
4 NEWCASTLE DISEASE VACCINE MARKET BY TYPE
4.1 Newcastle Disease Vaccine Type Introduction
4.1.1 Live Vaccines
4.1.2 Killed Vaccines
4.2 Global Newcastle Disease Vaccine Sales by Type
4.2.1 Global Newcastle Disease Vaccine Sales by Type (2019 VS 2023 VS 2030)
4.2.2 Global Newcastle Disease Vaccine Sales by Type (2019-2030)
4.2.3 Global Newcastle Disease Vaccine Sales Market Share by Type (2019-2030)
4.3 Global Newcastle Disease Vaccine Revenue by Type
4.3.1 Global Newcastle Disease Vaccine Revenue by Type (2019 VS 2023 VS 2030)
4.3.2 Global Newcastle Disease Vaccine Revenue by Type (2019-2030)
4.3.3 Global Newcastle Disease Vaccine Revenue Market Share by Type (2019-2030)
5 NEWCASTLE DISEASE VACCINE MARKET BY APPLICATION
5.1 Newcastle Disease Vaccine Application Introduction
5.1.1 Chicken
5.1.2 Duck & Goose
5.1.3 Other
5.2 Global Newcastle Disease Vaccine Sales by Application
5.2.1 Global Newcastle Disease Vaccine Sales by Application (2019 VS 2023 VS 2030)
5.2.2 Global Newcastle Disease Vaccine Sales by Application (2019-2030)
5.2.3 Global Newcastle Disease Vaccine Sales Market Share by Application (2019-2030)
5.3 Global Newcastle Disease Vaccine Revenue by Application
5.3.1 Global Newcastle Disease Vaccine Revenue by Application (2019 VS 2023 VS 2030)
5.3.2 Global Newcastle Disease Vaccine Revenue by Application (2019-2030)
5.3.3 Global Newcastle Disease Vaccine Revenue Market Share by Application (2019-2030)
6 GLOBAL NEWCASTLE DISEASE VACCINE SALES BY REGION
6.1 Global Newcastle Disease Vaccine Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Newcastle Disease Vaccine Sales by Region (2019-2030)
6.2.1 Global Newcastle Disease Vaccine Sales by Region (2019-2024)
6.2.2 Global Newcastle Disease Vaccine Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Newcastle Disease Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.3.2 North America Newcastle Disease Vaccine Sales by Country (2019-2030)
6.3.3 U.S.
6.3.4 Canada
6.4 Europe
6.4.1 Europe Newcastle Disease Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.4.2 Europe Newcastle Disease Vaccine Sales by Country (2019-2030)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Newcastle Disease Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.5.2 Asia Pacific Newcastle Disease Vaccine Sales by Country (2019-2030)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 LAMEA
6.6.1 LAMEA Newcastle Disease Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.6.2 LAMEA Newcastle Disease Vaccine Sales by Country (2019-2030)
6.6.3 Mexico
6.6.4 Brazil
6.6.5 Turkey
6.6.6 GCC Countries
7 GLOBAL NEWCASTLE DISEASE VACCINE REVENUE BY REGION
7.1 Global Newcastle Disease Vaccine Revenue by Region
7.1.1 Global Newcastle Disease Vaccine Revenue by Region: 2019 VS 2023 VS 2030
7.1.2 Global Newcastle Disease Vaccine Revenue by Region (2019-2024)
7.1.3 Global Newcastle Disease Vaccine Revenue by Region (2025-2030)
7.1.4 Global Newcastle Disease Vaccine Revenue Market Share by Region (2019-2030)
7.2 North America
7.2.1 North America Newcastle Disease Vaccine Revenue (2019-2030)
7.2.2 North America Newcastle Disease Vaccine Revenue Share by Country: 2019 VS 2023 VS 2030
7.3 Europe
7.3.1 Europe Newcastle Disease Vaccine Revenue (2019-2030)
7.3.2 Europe Newcastle Disease Vaccine Revenue Share by Country: 2019 VS 2023 VS 2030
7.4 Asia-Pacific
7.4.1 Asia-Pacific Newcastle Disease Vaccine Revenue (2019-2030)
7.4.2 Asia-Pacific Newcastle Disease Vaccine Revenue Share by Country: 2019 VS 2023 VS 2030
7.5 LAMEA
7.5.1 LAMEA Newcastle Disease Vaccine Revenue (2019-2030)
7.5.2 LAMEA Newcastle Disease Vaccine Revenue Share by Country: 2019 VS 2023 VS 2030
8 COMPANY PROFILES
8.1 Merial
8.1.1 Merial Comapny Information
8.1.2 Merial Business Overview
8.1.3 Merial Newcastle Disease Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.1.4 Merial Newcastle Disease Vaccine Product Portfolio
8.1.5 Merial Recent Developments
8.2 CEVA
8.2.1 CEVA Comapny Information
8.2.2 CEVA Business Overview
8.2.3 CEVA Newcastle Disease Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.2.4 CEVA Newcastle Disease Vaccine Product Portfolio
8.2.5 CEVA Recent Developments
8.3 QYH Biotech
8.3.1 QYH Biotech Comapny Information
8.3.2 QYH Biotech Business Overview
8.3.3 QYH Biotech Newcastle Disease Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.3.4 QYH Biotech Newcastle Disease Vaccine Product Portfolio
8.3.5 QYH Biotech Recent Developments
8.4 Ringpu Biology
8.4.1 Ringpu Biology Comapny Information
8.4.2 Ringpu Biology Business Overview
8.4.3 Ringpu Biology Newcastle Disease Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.4.4 Ringpu Biology Newcastle Disease Vaccine Product Portfolio
8.4.5 Ringpu Biology Recent Developments
8.5 Yebio
8.5.1 Yebio Comapny Information
8.5.2 Yebio Business Overview
8.5.3 Yebio Newcastle Disease Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.5.4 Yebio Newcastle Disease Vaccine Product Portfolio
8.5.5 Yebio Recent Developments
8.6 Harbin Veterinary Research Institute
8.6.1 Harbin Veterinary Research Institute Comapny Information
8.6.2 Harbin Veterinary Research Institute Business Overview
8.6.3 Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.6.4 Harbin Veterinary Research Institute Newcastle Disease Vaccine Product Portfolio
8.6.5 Harbin Veterinary Research Institute Recent Developments
8.7 Merck Animal Health
8.7.1 Merck Animal Health Comapny Information
8.7.2 Merck Animal Health Business Overview
8.7.3 Merck Animal Health Newcastle Disease Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.7.4 Merck Animal Health Newcastle Disease Vaccine Product Portfolio
8.7.5 Merck Animal Health Recent Developments
8.8 DHN
8.8.1 DHN Comapny Information
8.8.2 DHN Business Overview
8.8.3 DHN Newcastle Disease Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.8.4 DHN Newcastle Disease Vaccine Product Portfolio
8.8.5 DHN Recent Developments
8.9 Zoetis
8.9.1 Zoetis Comapny Information
8.9.2 Zoetis Business Overview
8.9.3 Zoetis Newcastle Disease Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.9.4 Zoetis Newcastle Disease Vaccine Product Portfolio
8.9.5 Zoetis Recent Developments
8.10 ChengDu Tecbond
8.10.1 ChengDu Tecbond Comapny Information
8.10.2 ChengDu Tecbond Business Overview
8.10.3 ChengDu Tecbond Newcastle Disease Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.10.4 ChengDu Tecbond Newcastle Disease Vaccine Product Portfolio
8.10.5 ChengDu Tecbond Recent Developments
8.11 Elanco (Lohmann)
8.11.1 Elanco (Lohmann) Comapny Information
8.11.2 Elanco (Lohmann) Business Overview
8.11.3 Elanco (Lohmann) Newcastle Disease Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.11.4 Elanco (Lohmann) Newcastle Disease Vaccine Product Portfolio
8.11.5 Elanco (Lohmann) Recent Developments
8.12 FATRO
8.12.1 FATRO Comapny Information
8.12.2 FATRO Business Overview
8.12.3 FATRO Newcastle Disease Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.12.4 FATRO Newcastle Disease Vaccine Product Portfolio
8.12.5 FATRO Recent Developments
8.13 CAVAC
8.13.1 CAVAC Comapny Information
8.13.2 CAVAC Business Overview
8.13.3 CAVAC Newcastle Disease Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.13.4 CAVAC Newcastle Disease Vaccine Product Portfolio
8.13.5 CAVAC Recent Developments
8.14 Vaksindo
8.14.1 Vaksindo Comapny Information
8.14.2 Vaksindo Business Overview
8.14.3 Vaksindo Newcastle Disease Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.14.4 Vaksindo Newcastle Disease Vaccine Product Portfolio
8.14.5 Vaksindo Recent Developments
9 VALUE CHAIN AND SALES CHANNELS ANALYSIS
9.1 Newcastle Disease Vaccine Value Chain Analysis
9.1.1 Newcastle Disease Vaccine Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Newcastle Disease Vaccine Production Mode & Process
9.2 Newcastle Disease Vaccine Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Newcastle Disease Vaccine Distributors
9.2.3 Newcastle Disease Vaccine Customers
10 CONCLUDING INSIGHTS
11 APPENDIX
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
1.1 Product Definition
1.2 Global Newcastle Disease Vaccine Market Size, 2019 VS 2023 VS 2030
1.3 Global Newcastle Disease Vaccine Market Size Estimates and Forecasts (2019-2030)
1.4 Global Newcastle Disease Vaccine Sales Estimates and Forecasts (2019-2030)
1.5 Global Newcastle Disease Vaccine Market Average Price (2019-2030)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 GLOBAL NEWCASTLE DISEASE VACCINE MARKET DYNAMICS
2.1 Newcastle Disease Vaccine Industry Trends
2.2 Newcastle Disease Vaccine Industry Drivers
2.3 Newcastle Disease Vaccine Industry Opportunities and Challenges
2.4 Newcastle Disease Vaccine Industry Restraints
3 NEWCASTLE DISEASE VACCINE MARKET BY MANUFACTURERS
3.1 Global Newcastle Disease Vaccine Revenue by Manufacturers (2019-2024)
3.2 Global Newcastle Disease Vaccine Sales by Manufacturers (2019-2024)
3.3 Global Newcastle Disease Vaccine Average Sales Price by Manufacturers (2019-2024)
3.4 Global Newcastle Disease Vaccine Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
3.5 Global Newcastle Disease Vaccine Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Newcastle Disease Vaccine Manufacturers, Product Type & Application
3.7 Global Newcastle Disease Vaccine Manufacturers Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Newcastle Disease Vaccine Market CR5 and HHI
3.8.2 Global Top 5 and 10 Newcastle Disease Vaccine Players Market Share by Revenue in 2023
3.8.3 2023 Newcastle Disease Vaccine Tier 1, Tier 2, and Tier
4 NEWCASTLE DISEASE VACCINE MARKET BY TYPE
4.1 Newcastle Disease Vaccine Type Introduction
4.1.1 Live Vaccines
4.1.2 Killed Vaccines
4.2 Global Newcastle Disease Vaccine Sales by Type
4.2.1 Global Newcastle Disease Vaccine Sales by Type (2019 VS 2023 VS 2030)
4.2.2 Global Newcastle Disease Vaccine Sales by Type (2019-2030)
4.2.3 Global Newcastle Disease Vaccine Sales Market Share by Type (2019-2030)
4.3 Global Newcastle Disease Vaccine Revenue by Type
4.3.1 Global Newcastle Disease Vaccine Revenue by Type (2019 VS 2023 VS 2030)
4.3.2 Global Newcastle Disease Vaccine Revenue by Type (2019-2030)
4.3.3 Global Newcastle Disease Vaccine Revenue Market Share by Type (2019-2030)
5 NEWCASTLE DISEASE VACCINE MARKET BY APPLICATION
5.1 Newcastle Disease Vaccine Application Introduction
5.1.1 Chicken
5.1.2 Duck & Goose
5.1.3 Other
5.2 Global Newcastle Disease Vaccine Sales by Application
5.2.1 Global Newcastle Disease Vaccine Sales by Application (2019 VS 2023 VS 2030)
5.2.2 Global Newcastle Disease Vaccine Sales by Application (2019-2030)
5.2.3 Global Newcastle Disease Vaccine Sales Market Share by Application (2019-2030)
5.3 Global Newcastle Disease Vaccine Revenue by Application
5.3.1 Global Newcastle Disease Vaccine Revenue by Application (2019 VS 2023 VS 2030)
5.3.2 Global Newcastle Disease Vaccine Revenue by Application (2019-2030)
5.3.3 Global Newcastle Disease Vaccine Revenue Market Share by Application (2019-2030)
6 GLOBAL NEWCASTLE DISEASE VACCINE SALES BY REGION
6.1 Global Newcastle Disease Vaccine Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Newcastle Disease Vaccine Sales by Region (2019-2030)
6.2.1 Global Newcastle Disease Vaccine Sales by Region (2019-2024)
6.2.2 Global Newcastle Disease Vaccine Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Newcastle Disease Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.3.2 North America Newcastle Disease Vaccine Sales by Country (2019-2030)
6.3.3 U.S.
6.3.4 Canada
6.4 Europe
6.4.1 Europe Newcastle Disease Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.4.2 Europe Newcastle Disease Vaccine Sales by Country (2019-2030)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Newcastle Disease Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.5.2 Asia Pacific Newcastle Disease Vaccine Sales by Country (2019-2030)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 LAMEA
6.6.1 LAMEA Newcastle Disease Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.6.2 LAMEA Newcastle Disease Vaccine Sales by Country (2019-2030)
6.6.3 Mexico
6.6.4 Brazil
6.6.5 Turkey
6.6.6 GCC Countries
7 GLOBAL NEWCASTLE DISEASE VACCINE REVENUE BY REGION
7.1 Global Newcastle Disease Vaccine Revenue by Region
7.1.1 Global Newcastle Disease Vaccine Revenue by Region: 2019 VS 2023 VS 2030
7.1.2 Global Newcastle Disease Vaccine Revenue by Region (2019-2024)
7.1.3 Global Newcastle Disease Vaccine Revenue by Region (2025-2030)
7.1.4 Global Newcastle Disease Vaccine Revenue Market Share by Region (2019-2030)
7.2 North America
7.2.1 North America Newcastle Disease Vaccine Revenue (2019-2030)
7.2.2 North America Newcastle Disease Vaccine Revenue Share by Country: 2019 VS 2023 VS 2030
7.3 Europe
7.3.1 Europe Newcastle Disease Vaccine Revenue (2019-2030)
7.3.2 Europe Newcastle Disease Vaccine Revenue Share by Country: 2019 VS 2023 VS 2030
7.4 Asia-Pacific
7.4.1 Asia-Pacific Newcastle Disease Vaccine Revenue (2019-2030)
7.4.2 Asia-Pacific Newcastle Disease Vaccine Revenue Share by Country: 2019 VS 2023 VS 2030
7.5 LAMEA
7.5.1 LAMEA Newcastle Disease Vaccine Revenue (2019-2030)
7.5.2 LAMEA Newcastle Disease Vaccine Revenue Share by Country: 2019 VS 2023 VS 2030
8 COMPANY PROFILES
8.1 Merial
8.1.1 Merial Comapny Information
8.1.2 Merial Business Overview
8.1.3 Merial Newcastle Disease Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.1.4 Merial Newcastle Disease Vaccine Product Portfolio
8.1.5 Merial Recent Developments
8.2 CEVA
8.2.1 CEVA Comapny Information
8.2.2 CEVA Business Overview
8.2.3 CEVA Newcastle Disease Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.2.4 CEVA Newcastle Disease Vaccine Product Portfolio
8.2.5 CEVA Recent Developments
8.3 QYH Biotech
8.3.1 QYH Biotech Comapny Information
8.3.2 QYH Biotech Business Overview
8.3.3 QYH Biotech Newcastle Disease Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.3.4 QYH Biotech Newcastle Disease Vaccine Product Portfolio
8.3.5 QYH Biotech Recent Developments
8.4 Ringpu Biology
8.4.1 Ringpu Biology Comapny Information
8.4.2 Ringpu Biology Business Overview
8.4.3 Ringpu Biology Newcastle Disease Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.4.4 Ringpu Biology Newcastle Disease Vaccine Product Portfolio
8.4.5 Ringpu Biology Recent Developments
8.5 Yebio
8.5.1 Yebio Comapny Information
8.5.2 Yebio Business Overview
8.5.3 Yebio Newcastle Disease Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.5.4 Yebio Newcastle Disease Vaccine Product Portfolio
8.5.5 Yebio Recent Developments
8.6 Harbin Veterinary Research Institute
8.6.1 Harbin Veterinary Research Institute Comapny Information
8.6.2 Harbin Veterinary Research Institute Business Overview
8.6.3 Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.6.4 Harbin Veterinary Research Institute Newcastle Disease Vaccine Product Portfolio
8.6.5 Harbin Veterinary Research Institute Recent Developments
8.7 Merck Animal Health
8.7.1 Merck Animal Health Comapny Information
8.7.2 Merck Animal Health Business Overview
8.7.3 Merck Animal Health Newcastle Disease Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.7.4 Merck Animal Health Newcastle Disease Vaccine Product Portfolio
8.7.5 Merck Animal Health Recent Developments
8.8 DHN
8.8.1 DHN Comapny Information
8.8.2 DHN Business Overview
8.8.3 DHN Newcastle Disease Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.8.4 DHN Newcastle Disease Vaccine Product Portfolio
8.8.5 DHN Recent Developments
8.9 Zoetis
8.9.1 Zoetis Comapny Information
8.9.2 Zoetis Business Overview
8.9.3 Zoetis Newcastle Disease Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.9.4 Zoetis Newcastle Disease Vaccine Product Portfolio
8.9.5 Zoetis Recent Developments
8.10 ChengDu Tecbond
8.10.1 ChengDu Tecbond Comapny Information
8.10.2 ChengDu Tecbond Business Overview
8.10.3 ChengDu Tecbond Newcastle Disease Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.10.4 ChengDu Tecbond Newcastle Disease Vaccine Product Portfolio
8.10.5 ChengDu Tecbond Recent Developments
8.11 Elanco (Lohmann)
8.11.1 Elanco (Lohmann) Comapny Information
8.11.2 Elanco (Lohmann) Business Overview
8.11.3 Elanco (Lohmann) Newcastle Disease Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.11.4 Elanco (Lohmann) Newcastle Disease Vaccine Product Portfolio
8.11.5 Elanco (Lohmann) Recent Developments
8.12 FATRO
8.12.1 FATRO Comapny Information
8.12.2 FATRO Business Overview
8.12.3 FATRO Newcastle Disease Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.12.4 FATRO Newcastle Disease Vaccine Product Portfolio
8.12.5 FATRO Recent Developments
8.13 CAVAC
8.13.1 CAVAC Comapny Information
8.13.2 CAVAC Business Overview
8.13.3 CAVAC Newcastle Disease Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.13.4 CAVAC Newcastle Disease Vaccine Product Portfolio
8.13.5 CAVAC Recent Developments
8.14 Vaksindo
8.14.1 Vaksindo Comapny Information
8.14.2 Vaksindo Business Overview
8.14.3 Vaksindo Newcastle Disease Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.14.4 Vaksindo Newcastle Disease Vaccine Product Portfolio
8.14.5 Vaksindo Recent Developments
9 VALUE CHAIN AND SALES CHANNELS ANALYSIS
9.1 Newcastle Disease Vaccine Value Chain Analysis
9.1.1 Newcastle Disease Vaccine Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Newcastle Disease Vaccine Production Mode & Process
9.2 Newcastle Disease Vaccine Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Newcastle Disease Vaccine Distributors
9.2.3 Newcastle Disease Vaccine Customers
10 CONCLUDING INSIGHTS
11 APPENDIX
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
LIST OF TABLES
Table 1. Newcastle Disease Vaccine Industry Trends
Table 2. Newcastle Disease Vaccine Industry Drivers
Table 3. Newcastle Disease Vaccine Industry Opportunities and Challenges
Table 4. Newcastle Disease Vaccine Industry Restraints
Table 5. Global Newcastle Disease Vaccine Revenue by Manufacturers (US$ Million) & (2019-2024)
Table 6. Global Newcastle Disease Vaccine Revenue Market Share by Manufacturers (2019-2024)
Table 7. Global Newcastle Disease Vaccine Sales by Manufacturers (M Doses) & (2019-2024)
Table 8. Global Newcastle Disease Vaccine Sales Market Share by Manufacturers
Table 9. Global Newcastle Disease Vaccine Average Sales Price (USD/K Doses) of Manufacturers (2019-2024)
Table 10. Global Newcastle Disease Vaccine Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
Table 11. Global Newcastle Disease Vaccine Key Manufacturers Manufacturing Sites & Headquarters
Table 12. Global Newcastle Disease Vaccine Manufacturers, Product Type & Application
Table 13. Global Newcastle Disease Vaccine Manufacturers Commercialization Time
Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Global Newcastle Disease Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 16. Major Manufacturers of Live Vaccines
Table 17. Major Manufacturers of Killed Vaccines
Table 18. Global Newcastle Disease Vaccine Sales by Type 2019 VS 2023 VS 2030 (M Doses)
Table 19. Global Newcastle Disease Vaccine Sales by Type (2019-2024) & (M Doses)
Table 20. Global Newcastle Disease Vaccine Sales by Type (2025-2030) & (M Doses)
Table 21. Global Newcastle Disease Vaccine Sales Market Share by Type (2019-2024)
Table 22. Global Newcastle Disease Vaccine Sales Market Share by Type (2025-2030)
Table 23. Global Newcastle Disease Vaccine Revenue by Type 2019 VS 2023 VS 2030 (M Doses)
Table 24. Global Newcastle Disease Vaccine Revenue by Type (2019-2024) & (M Doses)
Table 25. Global Newcastle Disease Vaccine Revenue by Type (2025-2030) & (M Doses)
Table 26. Global Newcastle Disease Vaccine Revenue Market Share by Type (2019-2024)
Table 27. Global Newcastle Disease Vaccine Revenue Market Share by Type (2025-2030)
Table 28. Major Manufacturers of Chicken
Table 29. Major Manufacturers of Duck & Goose
Table 30. Major Manufacturers of Other
Table 31. Global Newcastle Disease Vaccine Sales by Application 2019 VS 2023 VS 2030 (M Doses)
Table 32. Global Newcastle Disease Vaccine Sales by Application (2019-2024) & (M Doses)
Table 33. Global Newcastle Disease Vaccine Sales by Application (2025-2030) & (M Doses)
Table 34. Global Newcastle Disease Vaccine Sales Market Share by Application (2019-2024)
Table 35. Global Newcastle Disease Vaccine Sales Market Share by Application (2025-2030)
Table 36. Global Newcastle Disease Vaccine Revenue by Application 2019 VS 2023 VS 2030 (M Doses)
Table 37. Global Newcastle Disease Vaccine Revenue by Application (2019-2024) & (M Doses)
Table 38. Global Newcastle Disease Vaccine Revenue by Application (2025-2030) & (M Doses)
Table 39. Global Newcastle Disease Vaccine Revenue Market Share by Application (2019-2024)
Table 40. Global Newcastle Disease Vaccine Revenue Market Share by Application (2025-2030)
Table 41. Global Newcastle Disease Vaccine Sales by Region: 2019 VS 2023 VS 2030 (M Doses)
Table 42. Global Newcastle Disease Vaccine Sales by Region (2019-2024) & (M Doses)
Table 43. Global Newcastle Disease Vaccine Sales Market Share by Region (2019-2024)
Table 44. Global Newcastle Disease Vaccine Sales Forecasted by Region (2025-2030) & (M Doses)
Table 45. Global Newcastle Disease Vaccine Sales Forecasted Market Share by Region (2025-2030)
Table 46. North America Newcastle Disease Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (M Doses)
Table 47. North America Newcastle Disease Vaccine Sales by Country (2019-2024) & (M Doses)
Table 48. North America Newcastle Disease Vaccine Sales by Country (2025-2030) & (M Doses)
Table 49. Europe Newcastle Disease Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (M Doses)
Table 50. Europe Newcastle Disease Vaccine Sales by Country (2019-2024) & (M Doses)
Table 51. Europe Newcastle Disease Vaccine Sales by Country (2025-2030) & (M Doses)
Table 52. Asia Pacific Newcastle Disease Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (M Doses)
Table 53. Asia Pacific Newcastle Disease Vaccine Sales by Country (2019-2024) & (M Doses)
Table 54. Asia Pacific Newcastle Disease Vaccine Sales by Country (2025-2030) & (M Doses)
Table 55. LAMEA Newcastle Disease Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (M Doses)
Table 56. LAMEA Newcastle Disease Vaccine Sales by Country (2019-2024) & (M Doses)
Table 57. LAMEA Newcastle Disease Vaccine Sales by Country (2025-2030) & (M Doses)
Table 58. Global Newcastle Disease Vaccine Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 59. Global Newcastle Disease Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 60. Global Newcastle Disease Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 61. Global Newcastle Disease Vaccine Revenue Market Share by Region (2019-2024)
Table 62. Global Newcastle Disease Vaccine Revenue Market Share by Region (2025-2030)
Table 63. Merial Company Information
Table 64. Merial Business Overview
Table 65. Merial Newcastle Disease Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 66. Merial Newcastle Disease Vaccine Product Portfolio
Table 67. Merial Recent Development
Table 68. CEVA Company Information
Table 69. CEVA Business Overview
Table 70. CEVA Newcastle Disease Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 71. CEVA Newcastle Disease Vaccine Product Portfolio
Table 72. CEVA Recent Development
Table 73. QYH Biotech Company Information
Table 74. QYH Biotech Business Overview
Table 75. QYH Biotech Newcastle Disease Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 76. QYH Biotech Newcastle Disease Vaccine Product Portfolio
Table 77. QYH Biotech Recent Development
Table 78. Ringpu Biology Company Information
Table 79. Ringpu Biology Business Overview
Table 80. Ringpu Biology Newcastle Disease Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 81. Ringpu Biology Newcastle Disease Vaccine Product Portfolio
Table 82. Ringpu Biology Recent Development
Table 83. Yebio Company Information
Table 84. Yebio Business Overview
Table 85. Yebio Newcastle Disease Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 86. Yebio Newcastle Disease Vaccine Product Portfolio
Table 87. Yebio Recent Development
Table 88. Harbin Veterinary Research Institute Company Information
Table 89. Harbin Veterinary Research Institute Business Overview
Table 90. Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 91. Harbin Veterinary Research Institute Newcastle Disease Vaccine Product Portfolio
Table 92. Harbin Veterinary Research Institute Recent Development
Table 93. Merck Animal Health Company Information
Table 94. Merck Animal Health Business Overview
Table 95. Merck Animal Health Newcastle Disease Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 96. Merck Animal Health Newcastle Disease Vaccine Product Portfolio
Table 97. Merck Animal Health Recent Development
Table 98. DHN Company Information
Table 99. DHN Business Overview
Table 100. DHN Newcastle Disease Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 101. DHN Newcastle Disease Vaccine Product Portfolio
Table 102. DHN Recent Development
Table 103. Zoetis Company Information
Table 104. Zoetis Business Overview
Table 105. Zoetis Newcastle Disease Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 106. Zoetis Newcastle Disease Vaccine Product Portfolio
Table 107. Zoetis Recent Development
Table 108. ChengDu Tecbond Company Information
Table 109. ChengDu Tecbond Business Overview
Table 110. ChengDu Tecbond Newcastle Disease Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 111. ChengDu Tecbond Newcastle Disease Vaccine Product Portfolio
Table 112. ChengDu Tecbond Recent Development
Table 113. Elanco (Lohmann) Company Information
Table 114. Elanco (Lohmann) Business Overview
Table 115. Elanco (Lohmann) Newcastle Disease Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 116. Elanco (Lohmann) Newcastle Disease Vaccine Product Portfolio
Table 117. Elanco (Lohmann) Recent Development
Table 118. FATRO Company Information
Table 119. FATRO Business Overview
Table 120. FATRO Newcastle Disease Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 121. FATRO Newcastle Disease Vaccine Product Portfolio
Table 122. FATRO Recent Development
Table 123. CAVAC Company Information
Table 124. CAVAC Business Overview
Table 125. CAVAC Newcastle Disease Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 126. CAVAC Newcastle Disease Vaccine Product Portfolio
Table 127. CAVAC Recent Development
Table 128. Vaksindo Company Information
Table 129. Vaksindo Business Overview
Table 130. Vaksindo Newcastle Disease Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 131. Vaksindo Newcastle Disease Vaccine Product Portfolio
Table 132. Vaksindo Recent Development
Table 133. Key Raw Materials
Table 134. Raw Materials Key Suppliers
Table 135. Newcastle Disease Vaccine Distributors List
Table 136. Newcastle Disease Vaccine Customers List
Table 137. Research Programs/Design for This Report
Table 138. Authors List of This Report
Table 139. Secondary Sources
Table 140. Primary Sources
Table 1. Newcastle Disease Vaccine Industry Trends
Table 2. Newcastle Disease Vaccine Industry Drivers
Table 3. Newcastle Disease Vaccine Industry Opportunities and Challenges
Table 4. Newcastle Disease Vaccine Industry Restraints
Table 5. Global Newcastle Disease Vaccine Revenue by Manufacturers (US$ Million) & (2019-2024)
Table 6. Global Newcastle Disease Vaccine Revenue Market Share by Manufacturers (2019-2024)
Table 7. Global Newcastle Disease Vaccine Sales by Manufacturers (M Doses) & (2019-2024)
Table 8. Global Newcastle Disease Vaccine Sales Market Share by Manufacturers
Table 9. Global Newcastle Disease Vaccine Average Sales Price (USD/K Doses) of Manufacturers (2019-2024)
Table 10. Global Newcastle Disease Vaccine Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
Table 11. Global Newcastle Disease Vaccine Key Manufacturers Manufacturing Sites & Headquarters
Table 12. Global Newcastle Disease Vaccine Manufacturers, Product Type & Application
Table 13. Global Newcastle Disease Vaccine Manufacturers Commercialization Time
Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Global Newcastle Disease Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 16. Major Manufacturers of Live Vaccines
Table 17. Major Manufacturers of Killed Vaccines
Table 18. Global Newcastle Disease Vaccine Sales by Type 2019 VS 2023 VS 2030 (M Doses)
Table 19. Global Newcastle Disease Vaccine Sales by Type (2019-2024) & (M Doses)
Table 20. Global Newcastle Disease Vaccine Sales by Type (2025-2030) & (M Doses)
Table 21. Global Newcastle Disease Vaccine Sales Market Share by Type (2019-2024)
Table 22. Global Newcastle Disease Vaccine Sales Market Share by Type (2025-2030)
Table 23. Global Newcastle Disease Vaccine Revenue by Type 2019 VS 2023 VS 2030 (M Doses)
Table 24. Global Newcastle Disease Vaccine Revenue by Type (2019-2024) & (M Doses)
Table 25. Global Newcastle Disease Vaccine Revenue by Type (2025-2030) & (M Doses)
Table 26. Global Newcastle Disease Vaccine Revenue Market Share by Type (2019-2024)
Table 27. Global Newcastle Disease Vaccine Revenue Market Share by Type (2025-2030)
Table 28. Major Manufacturers of Chicken
Table 29. Major Manufacturers of Duck & Goose
Table 30. Major Manufacturers of Other
Table 31. Global Newcastle Disease Vaccine Sales by Application 2019 VS 2023 VS 2030 (M Doses)
Table 32. Global Newcastle Disease Vaccine Sales by Application (2019-2024) & (M Doses)
Table 33. Global Newcastle Disease Vaccine Sales by Application (2025-2030) & (M Doses)
Table 34. Global Newcastle Disease Vaccine Sales Market Share by Application (2019-2024)
Table 35. Global Newcastle Disease Vaccine Sales Market Share by Application (2025-2030)
Table 36. Global Newcastle Disease Vaccine Revenue by Application 2019 VS 2023 VS 2030 (M Doses)
Table 37. Global Newcastle Disease Vaccine Revenue by Application (2019-2024) & (M Doses)
Table 38. Global Newcastle Disease Vaccine Revenue by Application (2025-2030) & (M Doses)
Table 39. Global Newcastle Disease Vaccine Revenue Market Share by Application (2019-2024)
Table 40. Global Newcastle Disease Vaccine Revenue Market Share by Application (2025-2030)
Table 41. Global Newcastle Disease Vaccine Sales by Region: 2019 VS 2023 VS 2030 (M Doses)
Table 42. Global Newcastle Disease Vaccine Sales by Region (2019-2024) & (M Doses)
Table 43. Global Newcastle Disease Vaccine Sales Market Share by Region (2019-2024)
Table 44. Global Newcastle Disease Vaccine Sales Forecasted by Region (2025-2030) & (M Doses)
Table 45. Global Newcastle Disease Vaccine Sales Forecasted Market Share by Region (2025-2030)
Table 46. North America Newcastle Disease Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (M Doses)
Table 47. North America Newcastle Disease Vaccine Sales by Country (2019-2024) & (M Doses)
Table 48. North America Newcastle Disease Vaccine Sales by Country (2025-2030) & (M Doses)
Table 49. Europe Newcastle Disease Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (M Doses)
Table 50. Europe Newcastle Disease Vaccine Sales by Country (2019-2024) & (M Doses)
Table 51. Europe Newcastle Disease Vaccine Sales by Country (2025-2030) & (M Doses)
Table 52. Asia Pacific Newcastle Disease Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (M Doses)
Table 53. Asia Pacific Newcastle Disease Vaccine Sales by Country (2019-2024) & (M Doses)
Table 54. Asia Pacific Newcastle Disease Vaccine Sales by Country (2025-2030) & (M Doses)
Table 55. LAMEA Newcastle Disease Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (M Doses)
Table 56. LAMEA Newcastle Disease Vaccine Sales by Country (2019-2024) & (M Doses)
Table 57. LAMEA Newcastle Disease Vaccine Sales by Country (2025-2030) & (M Doses)
Table 58. Global Newcastle Disease Vaccine Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 59. Global Newcastle Disease Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 60. Global Newcastle Disease Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 61. Global Newcastle Disease Vaccine Revenue Market Share by Region (2019-2024)
Table 62. Global Newcastle Disease Vaccine Revenue Market Share by Region (2025-2030)
Table 63. Merial Company Information
Table 64. Merial Business Overview
Table 65. Merial Newcastle Disease Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 66. Merial Newcastle Disease Vaccine Product Portfolio
Table 67. Merial Recent Development
Table 68. CEVA Company Information
Table 69. CEVA Business Overview
Table 70. CEVA Newcastle Disease Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 71. CEVA Newcastle Disease Vaccine Product Portfolio
Table 72. CEVA Recent Development
Table 73. QYH Biotech Company Information
Table 74. QYH Biotech Business Overview
Table 75. QYH Biotech Newcastle Disease Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 76. QYH Biotech Newcastle Disease Vaccine Product Portfolio
Table 77. QYH Biotech Recent Development
Table 78. Ringpu Biology Company Information
Table 79. Ringpu Biology Business Overview
Table 80. Ringpu Biology Newcastle Disease Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 81. Ringpu Biology Newcastle Disease Vaccine Product Portfolio
Table 82. Ringpu Biology Recent Development
Table 83. Yebio Company Information
Table 84. Yebio Business Overview
Table 85. Yebio Newcastle Disease Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 86. Yebio Newcastle Disease Vaccine Product Portfolio
Table 87. Yebio Recent Development
Table 88. Harbin Veterinary Research Institute Company Information
Table 89. Harbin Veterinary Research Institute Business Overview
Table 90. Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 91. Harbin Veterinary Research Institute Newcastle Disease Vaccine Product Portfolio
Table 92. Harbin Veterinary Research Institute Recent Development
Table 93. Merck Animal Health Company Information
Table 94. Merck Animal Health Business Overview
Table 95. Merck Animal Health Newcastle Disease Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 96. Merck Animal Health Newcastle Disease Vaccine Product Portfolio
Table 97. Merck Animal Health Recent Development
Table 98. DHN Company Information
Table 99. DHN Business Overview
Table 100. DHN Newcastle Disease Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 101. DHN Newcastle Disease Vaccine Product Portfolio
Table 102. DHN Recent Development
Table 103. Zoetis Company Information
Table 104. Zoetis Business Overview
Table 105. Zoetis Newcastle Disease Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 106. Zoetis Newcastle Disease Vaccine Product Portfolio
Table 107. Zoetis Recent Development
Table 108. ChengDu Tecbond Company Information
Table 109. ChengDu Tecbond Business Overview
Table 110. ChengDu Tecbond Newcastle Disease Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 111. ChengDu Tecbond Newcastle Disease Vaccine Product Portfolio
Table 112. ChengDu Tecbond Recent Development
Table 113. Elanco (Lohmann) Company Information
Table 114. Elanco (Lohmann) Business Overview
Table 115. Elanco (Lohmann) Newcastle Disease Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 116. Elanco (Lohmann) Newcastle Disease Vaccine Product Portfolio
Table 117. Elanco (Lohmann) Recent Development
Table 118. FATRO Company Information
Table 119. FATRO Business Overview
Table 120. FATRO Newcastle Disease Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 121. FATRO Newcastle Disease Vaccine Product Portfolio
Table 122. FATRO Recent Development
Table 123. CAVAC Company Information
Table 124. CAVAC Business Overview
Table 125. CAVAC Newcastle Disease Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 126. CAVAC Newcastle Disease Vaccine Product Portfolio
Table 127. CAVAC Recent Development
Table 128. Vaksindo Company Information
Table 129. Vaksindo Business Overview
Table 130. Vaksindo Newcastle Disease Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 131. Vaksindo Newcastle Disease Vaccine Product Portfolio
Table 132. Vaksindo Recent Development
Table 133. Key Raw Materials
Table 134. Raw Materials Key Suppliers
Table 135. Newcastle Disease Vaccine Distributors List
Table 136. Newcastle Disease Vaccine Customers List
Table 137. Research Programs/Design for This Report
Table 138. Authors List of This Report
Table 139. Secondary Sources
Table 140. Primary Sources
LIST OF FIGURES
Figure 1. Newcastle Disease Vaccine Product Picture
Figure 2. Global Newcastle Disease Vaccine Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Newcastle Disease Vaccine Market Size (2019-2030) & (US$ Million)
Figure 4. Global Newcastle Disease Vaccine Sales (2019-2030) & (M Doses)
Figure 5. Global Newcastle Disease Vaccine Average Price (USD/K Doses) & (2019-2030)
Figure 6. Global Top 5 and 10 Newcastle Disease Vaccine Players Market Share by Revenue in 2023
Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Live Vaccines Picture
Figure 9. Killed Vaccines Picture
Figure 10. Global Newcastle Disease Vaccine Sales by Type (2019 VS 2023 VS 2030) & (M Doses)
Figure 11. Global Newcastle Disease Vaccine Sales Market Share 2019 VS 2023 VS 2030
Figure 12. Global Newcastle Disease Vaccine Sales Market Share by Type (2019-2030)
Figure 13. Global Newcastle Disease Vaccine Revenue by Type (2019 VS 2023 VS 2030) & (M Doses)
Figure 14. Global Newcastle Disease Vaccine Revenue Market Share 2019 VS 2023 VS 2030
Figure 15. Global Newcastle Disease Vaccine Revenue Market Share by Type (2019-2030)
Figure 16. Chicken Picture
Figure 17. Duck & Goose Picture
Figure 18. Other Picture
Figure 19. Global Newcastle Disease Vaccine Sales by Application (2019 VS 2023 VS 2030) & (M Doses)
Figure 20. Global Newcastle Disease Vaccine Sales Market Share 2019 VS 2023 VS 2030
Figure 21. Global Newcastle Disease Vaccine Sales Market Share by Application (2019-2030)
Figure 22. Global Newcastle Disease Vaccine Revenue by Application (2019 VS 2023 VS 2030) & (M Doses)
Figure 23. Global Newcastle Disease Vaccine Revenue Market Share 2019 VS 2023 VS 2030
Figure 24. Global Newcastle Disease Vaccine Revenue Market Share by Application (2019-2030)
Figure 25. North America Newcastle Disease Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 26. North America Newcastle Disease Vaccine Sales Market Share by Country (2019-2030)
Figure 27. U.S. Newcastle Disease Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 28. Canada Newcastle Disease Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 29. Europe Newcastle Disease Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 30. Europe Newcastle Disease Vaccine Sales Market Share by Country (2019-2030)
Figure 31. Germany Newcastle Disease Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 32. France Newcastle Disease Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 33. U.K. Newcastle Disease Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 34. Italy Newcastle Disease Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 35. Netherlands Newcastle Disease Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 36. Asia Pacific Newcastle Disease Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 37. Asia Pacific Newcastle Disease Vaccine Sales Market Share by Country (2019-2030)
Figure 38. China Newcastle Disease Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 39. Japan Newcastle Disease Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 40. South Korea Newcastle Disease Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 41. Southeast Asia Newcastle Disease Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 42. India Newcastle Disease Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 43. Australia Newcastle Disease Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 44. LAMEA Newcastle Disease Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 45. LAMEA Newcastle Disease Vaccine Sales Market Share by Country (2019-2030)
Figure 46. Mexico Newcastle Disease Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 47. Brazil Newcastle Disease Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 48. Turkey Newcastle Disease Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 49. GCC Countries Newcastle Disease Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 50. Global Newcastle Disease Vaccine Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 51. Global Newcastle Disease Vaccine Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 52. North America Newcastle Disease Vaccine Revenue (2019-2030) & (US$ Million)
Figure 53. North America Newcastle Disease Vaccine Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 54. Europe Newcastle Disease Vaccine Revenue (2019-2030) & (US$ Million)
Figure 55. Europe Newcastle Disease Vaccine Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 56. Asia-Pacific Newcastle Disease Vaccine Revenue (2019-2030) & (US$ Million)
Figure 57. Asia-Pacific Newcastle Disease Vaccine Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 58. LAMEA Newcastle Disease Vaccine Revenue (2019-2030) & (US$ Million)
Figure 59. LAMEA Newcastle Disease Vaccine Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 60. Newcastle Disease Vaccine Value Chain
Figure 61. Manufacturing Cost Structure
Figure 62. Newcastle Disease Vaccine Production Mode & Process
Figure 63. Direct Comparison with Distribution Share
Figure 64. Distributors Profiles
Figure 65. Years Considered
Figure 66. Research Process
Figure 67. Key Executives Interviewed
Figure 1. Newcastle Disease Vaccine Product Picture
Figure 2. Global Newcastle Disease Vaccine Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Newcastle Disease Vaccine Market Size (2019-2030) & (US$ Million)
Figure 4. Global Newcastle Disease Vaccine Sales (2019-2030) & (M Doses)
Figure 5. Global Newcastle Disease Vaccine Average Price (USD/K Doses) & (2019-2030)
Figure 6. Global Top 5 and 10 Newcastle Disease Vaccine Players Market Share by Revenue in 2023
Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Live Vaccines Picture
Figure 9. Killed Vaccines Picture
Figure 10. Global Newcastle Disease Vaccine Sales by Type (2019 VS 2023 VS 2030) & (M Doses)
Figure 11. Global Newcastle Disease Vaccine Sales Market Share 2019 VS 2023 VS 2030
Figure 12. Global Newcastle Disease Vaccine Sales Market Share by Type (2019-2030)
Figure 13. Global Newcastle Disease Vaccine Revenue by Type (2019 VS 2023 VS 2030) & (M Doses)
Figure 14. Global Newcastle Disease Vaccine Revenue Market Share 2019 VS 2023 VS 2030
Figure 15. Global Newcastle Disease Vaccine Revenue Market Share by Type (2019-2030)
Figure 16. Chicken Picture
Figure 17. Duck & Goose Picture
Figure 18. Other Picture
Figure 19. Global Newcastle Disease Vaccine Sales by Application (2019 VS 2023 VS 2030) & (M Doses)
Figure 20. Global Newcastle Disease Vaccine Sales Market Share 2019 VS 2023 VS 2030
Figure 21. Global Newcastle Disease Vaccine Sales Market Share by Application (2019-2030)
Figure 22. Global Newcastle Disease Vaccine Revenue by Application (2019 VS 2023 VS 2030) & (M Doses)
Figure 23. Global Newcastle Disease Vaccine Revenue Market Share 2019 VS 2023 VS 2030
Figure 24. Global Newcastle Disease Vaccine Revenue Market Share by Application (2019-2030)
Figure 25. North America Newcastle Disease Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 26. North America Newcastle Disease Vaccine Sales Market Share by Country (2019-2030)
Figure 27. U.S. Newcastle Disease Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 28. Canada Newcastle Disease Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 29. Europe Newcastle Disease Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 30. Europe Newcastle Disease Vaccine Sales Market Share by Country (2019-2030)
Figure 31. Germany Newcastle Disease Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 32. France Newcastle Disease Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 33. U.K. Newcastle Disease Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 34. Italy Newcastle Disease Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 35. Netherlands Newcastle Disease Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 36. Asia Pacific Newcastle Disease Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 37. Asia Pacific Newcastle Disease Vaccine Sales Market Share by Country (2019-2030)
Figure 38. China Newcastle Disease Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 39. Japan Newcastle Disease Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 40. South Korea Newcastle Disease Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 41. Southeast Asia Newcastle Disease Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 42. India Newcastle Disease Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 43. Australia Newcastle Disease Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 44. LAMEA Newcastle Disease Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 45. LAMEA Newcastle Disease Vaccine Sales Market Share by Country (2019-2030)
Figure 46. Mexico Newcastle Disease Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 47. Brazil Newcastle Disease Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 48. Turkey Newcastle Disease Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 49. GCC Countries Newcastle Disease Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 50. Global Newcastle Disease Vaccine Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 51. Global Newcastle Disease Vaccine Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 52. North America Newcastle Disease Vaccine Revenue (2019-2030) & (US$ Million)
Figure 53. North America Newcastle Disease Vaccine Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 54. Europe Newcastle Disease Vaccine Revenue (2019-2030) & (US$ Million)
Figure 55. Europe Newcastle Disease Vaccine Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 56. Asia-Pacific Newcastle Disease Vaccine Revenue (2019-2030) & (US$ Million)
Figure 57. Asia-Pacific Newcastle Disease Vaccine Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 58. LAMEA Newcastle Disease Vaccine Revenue (2019-2030) & (US$ Million)
Figure 59. LAMEA Newcastle Disease Vaccine Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 60. Newcastle Disease Vaccine Value Chain
Figure 61. Manufacturing Cost Structure
Figure 62. Newcastle Disease Vaccine Production Mode & Process
Figure 63. Direct Comparison with Distribution Share
Figure 64. Distributors Profiles
Figure 65. Years Considered
Figure 66. Research Process
Figure 67. Key Executives Interviewed
